Home › Trial NCT05243862
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
- Trial IDNCT05243862
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorTreos Bio Limited
- Enrollment18
- Start date2022-06-02
- ConditionsColorectal Cancer Metastatic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.